- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
- 中期趋势：
回落整理中且下跌趋势有所减缓。
- 长期趋势：
已有233家主力机构披露2024-06-30报告期持股数据，持仓量总计7.76亿股，占流通A股49.29%
- 波段诊断：
-
技术面诊股
诊断结果：6.9技术面打败了83%的股票
技术面评分前10的股票
近期的平均成本为17.25元。多头行情中，目前处于回落整理阶段且下跌趋势有所减缓。
平均成本
近期的平均成本为17.25元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"17.25","date":1732089390,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑赢大盘，接近行业平均水平。
[{"date":"2024.11.21","stock":"1.28","trade":"0.22","ind":"-0.07"},{"date":"2024.11.20","stock":"0.82","trade":"2.52","ind":"0.78"},{"date":"2024.11.19","stock":"1.61","trade":"2.19","ind":"1.90"},{"date":"2024.11.18","stock":"-1.06","trade":"-2.07","ind":"-1.91"},{"date":"2024.11.15","stock":"-1.45","trade":"-2.51","ind":"-2.62"},{"date":"2024.11.14","stock":"-2.55","trade":"-3.03","ind":"-2.83"},{"date":"2024.11.13","stock":"-0.90","trade":"-1.31","ind":"0.40"},{"date":"2024.11.12","stock":"0.45","trade":"0.55","ind":"-0.65"},{"date":"2024.11.11","stock":"0.97","trade":"2.28","ind":"2.03"},{"date":"2024.11.08","stock":"-0.28","trade":"-0.32","ind":"-0.66"},{"date":"2024.11.07","stock":"2.27","trade":"2.56","ind":"2.44"},{"date":"2024.11.06","stock":"-0.17","trade":"-0.13","ind":"-0.35"},{"date":"2024.11.05","stock":"3.05","trade":"2.58","ind":"3.22"},{"date":"2024.11.04","stock":"1.89","trade":"1.73","ind":"1.99"},{"date":"2024.11.01","stock":"-0.36","trade":"-1.43","ind":"-1.28"},{"date":"2024.10.31","stock":"-0.66","trade":"0.45","ind":"0.57"},{"date":"2024.10.30","stock":"0.12","trade":"-1.33","ind":"-0.12"},{"date":"2024.10.29","stock":"-2.59","trade":"-3.08","ind":"-1.33"},{"date":"2024.10.28","stock":"1.80","trade":"1.23","ind":"0.62"},{"date":"2024.10.25","stock":"0.91","trade":"1.14","ind":"1.71"},{"date":"2024.10.24","stock":"1.10","trade":"1.77","ind":"-1.27"}]
华兰生物,深证成指,生物制品指数
压力支撑
该股压力位为17.19元，支撑位为16.91元。
[{"text":"\u538b\u529b\u4f4d","value":"17.19","date":1732118400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"16.91","date":1732118400,"color":"0x0b52a1"}]
多空趋势
多头行情中，目前处于回落整理阶段且下跌趋势有所减缓。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.3资金面打败了28%的股票
主力控盘前10的股票
行业资金
生物制品行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：11月21日 17:13
| 机构今日流向(万元) | -2566.03 | 机构5日流向(万元) | -5593.51 |
| 机构10日流向(万元) | -12534.28 | 机构20日流向(万元) | -16200.99 |
机构持仓
2024-06-30 与 2023-12-31 相比，主力机构持仓量减少6021.62万股，其中基金净减仓4家，主力净减仓131家，请投资者中长期谨慎为宜。
截止2024-06-30，共233家主力机构（基金228家，一般法人5家），持仓量总计77573.76万股，占流通A股49.29%
其中，基金持仓与2023-12-31相比：
增仓：85家 ，增持 2166.68万股
减仓：89家 ，减持 705.41万股
新出现在主力名单中：34家 ，持有2083.96万股
从主力名单中消失：165家 ，原持有3447.17万股
其中，基金持仓与2023-12-31相比：
增仓：85家 ，增持 2166.68万股
减仓：89家 ，减持 705.41万股
新出现在主力名单中：34家 ，持有2083.96万股
从主力名单中消失：165家 ，原持有3447.17万股
消息面诊股
诊断结果：5.5消息面打败了12%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 华兰生物：11月20日获融资买入897.82万元，
2024-11-21 - 华兰生物：11月19日获融资买入1101.53万元
2024-11-20 - 华兰生物：11月18日融券卖出金额17.93万元，
2024-11-19 - 2024年11月19日早间个股预警：东方集团控股股
2024-11-19 - 华兰生物将于11月22日解禁132.43万股
2024-11-18 - 华兰生物：11月15日融券卖出金额45.91万元，
2024-11-18 - 行业周报|生物制品指数跌-4.05%, 跑输上证指
2024-11-15 - 华兰生物11月22日解禁132.43万股，市值约2
2024-11-15 - 华兰生物：11月13日融券卖出金额5292.00元
2024-11-14 - 华兰生物(11月13日)现大宗交易
2024-11-13
消息列表
| 一般消息 | 分红转增 | 不分配不转增 | 2024-08-30 |
| 一般消息 | 股东大会 | 年度股东大会 | 2024-03-30 |
| 利好 | 分红转增 | 10派3元(含税) | 2024-03-30 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 1条 | 0条 | 1条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：6.5行业面打败了79%的股票
生物制品行业最新资金流向
近10日来该行业走势不明显，跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑赢大盘。
[{"date":"2024.11.21","price":"-0.07","value":"0.22"},{"date":"2024.11.20","price":"0.78","value":"2.52"},{"date":"2024.11.19","price":"1.90","value":"2.19"},{"date":"2024.11.18","price":"-1.91","value":"-2.07"},{"date":"2024.11.15","price":"-2.62","value":"-2.51"},{"date":"2024.11.14","price":"-2.83","value":"-3.03"},{"date":"2024.11.13","price":"0.40","value":"-1.31"},{"date":"2024.11.12","price":"-0.65","value":"0.55"},{"date":"2024.11.11","price":"2.03","value":"2.28"},{"date":"2024.11.08","price":"-0.66","value":"-0.32"},{"date":"2024.11.07","price":"2.44","value":"2.56"},{"date":"2024.11.06","price":"-0.35","value":"-0.13"},{"date":"2024.11.05","price":"3.22","value":"2.58"},{"date":"2024.11.04","price":"1.99","value":"1.73"},{"date":"2024.11.01","price":"-1.28","value":"-1.43"},{"date":"2024.10.31","price":"0.57","value":"0.45"},{"date":"2024.10.30","price":"-0.12","value":"-1.33"},{"date":"2024.10.29","price":"-1.33","value":"-3.08"},{"date":"2024.10.28","price":"0.62","value":"1.23"},{"date":"2024.10.25","price":"1.71","value":"1.14"},{"date":"2024.10.24","price":"-1.27","value":"1.77"}]
深证成指,生物制品行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 四环生物 | 32.03% | 8.68% | 6.0分 |
| 2 | 荣昌生物 | 23.52% | 9.71% | 5.8分 |
| 3 | 康希诺 | 19.86% | -0.59% | 4.9分 |
| 4 | 百普赛斯 | 14.81% | 1.20% | 5.2分 |
| 5 | 金迪克 | 12.35% | -3.07% | 4.5分 |
| 6 | 万泽股份 | 12.12% | 4.55% | 6.6分 |
| 8 | 长春高新 | 9.92% | 0.92% | 5.2分 |
| 10 | 辽宁成大 | 6.87% | 0.68% | 4.3分 |
| 12 | 康辰药业 | 5.77% | 2.30% | 5.5分 |
| 14 | 诺唯赞 | 5.30% | -3.21% | 5.1分 |
| 16 | 优宁维 | 4.70% | -0.09% | 5.7分 |
| 18 | 通化东宝 | 3.95% | -0.46% | 4.6分 |
| 20 | 东宝生物 | 2.78% | 2.59% | 5.7分 |
| 22 | 成大生物 | 2.06% | 0.04% | 4.5分 |
| 24 | 诺诚健华 | 1.33% | 6.70% | 5.0分 |
| 26 | 华兰疫苗 | 1.00% | 0.30% | 5.8分 |
| 28 | 迈威生物 | -0.33% | -2.73% | 5.0分 |
| 30 | 天坛生物 | -0.72% | -0.72% | 5.3分 |
| 32 | 康弘药业 | -1.43% | 2.45% | 6.5分 |
| 34 | 沃森生物 | -2.61% | -3.59% | 5.0分 |
| 36 | 赛伦生物 | -2.62% | -2.24% | 4.2分 |
| 38 | 安科生物 | -2.67% | -2.57% | 5.0分 |
| 40 | 万泰生物 | -3.25% | 0.24% | 5.2分 |
| 42 | 君实生物 | -4.30% | 0.26% | 4.7分 |
| 44 | 智翔金泰 | -4.77% | -2.34% | 3.7分 |
| 46 | 我武生物 | -6.69% | -3.36% | 4.8分 |
| 48 | 百克生物 | -7.88% | -2.65% | 4.9分 |
| 50 | 甘李药业 | -9.56% | -0.81% | 4.6分 |
| 52 | 特宝生物 | -10.24% | -2.16% | 4.9分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2024-09-30 ]公司经营
盈利能力：较强，高于行业平均，两项指标的行业排名分别为 11/73 ， 40/73。
[{"date":"2024-09-30","value":"8.01","vol":"1.38"},{"date":"2024-06-30","value":"3.89","vol":"0.75"},{"date":"2024-03-31","value":"2.28","vol":"0.43"},{"date":"2023-12-31","value":"13.62","vol":"1.90"},{"date":"2023-09-30","value":"10.01","vol":"3.06"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
8.01 | 3.89 | 2.28 | 13.62 | 10.01 |
| 行业(%) | 1.38 | 0.75 | 0.43 | 1.90 | 3.06 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"61.77","vol":"70.59"},{"date":"2024-06-30","value":"50.69","vol":"69.95"},{"date":"2024-03-31","value":"55.68","vol":"70.47"},{"date":"2023-12-31","value":"69.59","vol":"69.93"},{"date":"2023-09-30","value":"69.64","vol":"69.71"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
61.77 | 50.69 | 55.68 | 69.59 | 69.64 |
| 行业(%) | 70.59 | 69.95 | 70.47 | 69.93 | 69.71 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：较强，高于行业平均，两项指标的行业排名分别为 37/73 ， 31/73。
[{"date":"2024-09-30","value":"-10.79","vol":"173.80"},{"date":"2024-06-30","value":"4.26","vol":"17.95"},{"date":"2024-03-31","value":"-10.60","vol":"29.19"},{"date":"2023-12-31","value":"18.26","vol":"18.84"},{"date":"2023-09-30","value":"8.62","vol":"15.35"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-10.79 | 4.26 | -10.60 | 18.26 | 8.62 |
| 行业(%) | 173.80 | 17.95 | 29.19 | 18.84 | 15.35 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"-13.46","vol":"-54.20"},{"date":"2024-06-30","value":"-16.42","vol":"-10.79"},{"date":"2024-03-31","value":"-25.56","vol":"-528.49"},{"date":"2023-12-31","value":"37.66","vol":"-34.06"},{"date":"2023-09-30","value":"18.51","vol":"272.44"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-13.46 | -16.42 | -25.56 | 37.66 | 18.51 |
| 行业(%) | -54.20 | -10.79 | -528.49 | -34.06 | 272.44 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，两项指标的行业排名分别为 21/73 ， 23/73。
[{"date":"2024-09-30","value":"0.22","vol":"0.22"},{"date":"2024-06-30","value":"0.10","vol":"0.14"},{"date":"2024-03-31","value":"0.05","vol":"0.07"},{"date":"2023-12-31","value":"0.35","vol":"0.33"},{"date":"2023-09-30","value":"0.26","vol":"0.24"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.22 | 0.10 | 0.05 | 0.35 | 0.26 |
| 行业(次) | 0.22 | 0.14 | 0.07 | 0.33 | 0.24 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"0.75","vol":"0.87"},{"date":"2024-06-30","value":"0.45","vol":"0.55"},{"date":"2024-03-31","value":"0.19","vol":"0.26"},{"date":"2023-12-31","value":"1.04","vol":"1.31"},{"date":"2023-09-30","value":"0.75","vol":"0.93"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.75 | 0.45 | 0.19 | 1.04 | 0.75 |
| 行业(次) | 0.87 | 0.55 | 0.26 | 1.31 | 0.93 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2024-09-30","value":"7.53","vol":"-28.68"},{"date":"2024-06-30","value":"31.33","vol":"-36165.87"},{"date":"2024-03-31","value":"6.37","vol":"-43943.29"},{"date":"2023-12-31","value":"45.71","vol":"-170.97"},{"date":"2023-09-30","value":"-3.21","vol":"-29016.32"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 7.53 | 31.33 | 6.37 | 45.71 | -3.21 |
| 行业 | -28.68 | -36165.87 | -43943.29 | -170.97 | -29016.32 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"1.94","vol":"2.73"},{"date":"2024-03-31","value":"","vol":"0.00"},{"date":"2023-12-31","value":"2.75","vol":"2.86"},{"date":"2023-09-30","value":"","vol":"0.00"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 1.94 | - | 2.75 | - |
| 行业 | 0.00 | 2.73 | 0.00 | 2.86 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，居行业前列，两项指标的行业排名分别为 27/73 ， 22/73。
[{"date":"2024-09-30","value":"4.05","vol":"7.11"},{"date":"2024-06-30","value":"3.86","vol":"6.99"},{"date":"2024-03-31","value":"4.01","vol":"8.01"},{"date":"2023-12-31","value":"3.61","vol":"7.53"},{"date":"2023-09-30","value":"3.88","vol":"8.24"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
4.05 | 3.86 | 4.01 | 3.61 | 3.88 |
| 行业 | 7.11 | 6.99 | 8.01 | 7.53 | 8.24 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"2.25","vol":"5.73"},{"date":"2024-06-30","value":"2.41","vol":"5.87"},{"date":"2024-03-31","value":"2.68","vol":"6.87"},{"date":"2023-12-31","value":"2.21","vol":"6.45"},{"date":"2023-09-30","value":"2.69","vol":"7.25"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
2.25 | 2.41 | 2.68 | 2.21 | 2.69 |
| 行业 | 5.73 | 5.87 | 6.87 | 6.45 | 7.25 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，两项指标的行业排名分别为 30/73 ， 28/73。
[{"date":"2024-09-30","value":"14.85","vol":"24.72"},{"date":"2024-06-30","value":"15.55","vol":"24.44"},{"date":"2024-03-31","value":"15.74","vol":"23.84"},{"date":"2023-12-31","value":"16.67","vol":"23.96"},{"date":"2023-09-30","value":"16.83","vol":"22.75"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
14.85 | 15.55 | 15.74 | 16.67 | 16.83 |
| 行业(%) | 24.72 | 24.44 | 23.84 | 23.96 | 22.75 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"0.20","vol":"0.40"},{"date":"2024-06-30","value":"0.22","vol":"0.38"},{"date":"2024-03-31","value":"0.22","vol":"0.36"},{"date":"2023-12-31","value":"0.24","vol":"0.35"},{"date":"2023-09-30","value":"0.24","vol":"0.32"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.20 | 0.22 | 0.22 | 0.24 | 0.24 |
| 行业(%) | 0.40 | 0.38 | 0.36 | 0.35 | 0.32 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 兴业证券 | 2024-11-08 | 增持 | |
| 中信建投证券 | 2024-11-06 | 买入 | 买入 |
| 华泰金融(HK) | 2024-11-05 | 买入 | 买入 |
| 中原证券 | 2024-11-04 | 买入 | 买入 |
| 中邮证券 | 2024-11-04 | 买入 | 买入 |
| 野村东方国际证券 | 2024-11-03 | 增持 |
机构预测
机构预测该股2024年每股收益与前一年相同，长期投资价值一般。
[{"date":"2020","yellowRectValue":"16.13","blueLineValue":"","type":""},{"date":"2021","yellowRectValue":"12.99","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"10.76","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"14.82","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"13.77","blueLineValue":"0.75","type":"YC"}]